| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 09/26/2002 | WO2002074750A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074749A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074748A1 Metalloproteinase inhibitors |
| 09/26/2002 | WO2002074747A1 Farnesyltransferase inhibitors |
| 09/26/2002 | WO2002074740A1 Biguanide derivatives |
| 09/26/2002 | WO2002074731A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 09/26/2002 | WO2002074268A2 Dyeing compositions for the dyeing of keratin fibres, comprising heterocyclic hydrazone compounds |
| 09/26/2002 | WO2002040484A3 Novel imidazole derivatives, production method thereof and use thereof |
| 09/26/2002 | WO2002036116A3 Tripeptidyl peptidase inhibitors |
| 09/26/2002 | WO2002034698A3 Phosgene-free process for preparing carbamates |
| 09/26/2002 | WO2002028810A3 Retinoids for the treatment of emphysema |
| 09/26/2002 | WO2002024636A3 N-acylsulfonamide apoptosis promoters |
| 09/26/2002 | WO2001052847A8 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 09/26/2002 | WO1997019953A8 New lh-rh antagonists with improved effectiveness |
| 09/26/2002 | US20020137968 Treating with amides, ureas, amidines, carbamates, carboximidamides and other derivatives of given formula, e.g. (+)-N-((2,2-dimethylcyclopentyl)methyl)-4-hexyloxybenzamide |
| 09/26/2002 | US20020137943 Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulation |
| 09/26/2002 | US20020137942 HIV protease inhibitors; administering to treat AIDS (acquired immune deficiency syndrome) |
| 09/26/2002 | US20020137939 Novel guanidinobenzamides |
| 09/26/2002 | US20020137730 Positively charged non-natural amino acids, methods of making and using thereof in peptides |
| 09/26/2002 | US20020137638 Oil-soluble additive compositions for lubricating oils |
| 09/26/2002 | US20020137224 Method for determination of 5-hydroxycreatinine |
| 09/26/2002 | US20020137054 AXOR35, a G-protein coupled receptor |
| 09/26/2002 | CA2445754A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 09/26/2002 | CA2444526A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440632A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440631A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440475A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2430619A1 Farnesyltransferase inhibitors |
| 09/25/2002 | EP1243582A1 Quinoline and quinazoline derivatives and drugs containing the same |
| 09/25/2002 | EP1243580A1 Heterocyclic imino compounds and fungicides and insecticides for agricultural and horticultural use |
| 09/25/2002 | EP1243577A1 Novel phenylalanine derivatives |
| 09/25/2002 | EP1243261A1 Use of a hydantoin derivative in a pharmaceutical composition against hypoalbuminaemia |
| 09/25/2002 | EP1242427A1 Novel piperidine and piperazine derivatives |
| 09/25/2002 | EP1242364A1 Adamantane derivatives |
| 09/25/2002 | EP1210334A4 Process of making imidazolidine-2-one derivatives |
| 09/25/2002 | EP1181279A4 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
| 09/25/2002 | EP0977559B1 Enhanced anti-cancer agent delivery to solid tumors by primer compounds |
| 09/25/2002 | EP0968179B1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides |
| 09/25/2002 | EP0915854B1 Curable mixtures based on epoxy resins comprising imidazoles |
| 09/25/2002 | EP0746312B1 Guanylhydrazones for treating inflammatory conditions |
| 09/25/2002 | CN1370602A Steam sterilization utilizing water-free hydrogen peroxide source |
| 09/25/2002 | CN1091443C New imidazoline compounds, process for preparing them and pharmaceutical composition containing them |
| 09/24/2002 | US6455737 Cationic dyes and oxidation bases having intense shades or colors and colorfastness used on human keratin fibers such as hair; multicompartment kits |
| 09/24/2002 | US6455714 Labeled vitamin D compounds and the use thereof |
| 09/24/2002 | US6455702 Process for the production of N,N-carbonyl diimidazole |
| 09/24/2002 | US6455700 Process for preparing guanidine and amidine derivatives |
| 09/24/2002 | US6455662 Curing agent, catalyst, accelerator of a derivative of 1-(hydrocarbyloxycarbonyl)imidazole; latency at room temperature; high activity upon heating; molding materials; coatings; bonding; lamination; foams; electrical devices |
| 09/24/2002 | US6455581 Inhibitors of hiv protease. |
| 09/24/2002 | US6455550 N-alkanoylphenylalanine derivatives |
| 09/24/2002 | US6455528 Tumor necrosis factor antagonist and/or interleukin promoter; antiallergens, antiinflammatory agents; autoimmune disease treatment |
| 09/24/2002 | US6455505 Derivatives . . . use as medicaments |
| 09/24/2002 | US6455502 Compounds and compositions as protease inhibitors |
| 09/24/2002 | US6455241 Element exhibits improved dye-forming activity and improved combination of dye hue and dye stability |
| 09/20/2002 | WO2001070704A1 Novel imidazole derivatives with anti-inflammatory activity |
| 09/20/2002 | CA2403732A1 Novel imidazole derivatives with anti-inflammatory activity |
| 09/19/2002 | WO2002072573A1 Imidazolidine derivatives, their preparation, and their use as antinflamatory agent. |
| 09/19/2002 | WO2002072568A1 N-heteroarylmethyl-m-phenylenediamine derivative-containing dyes for keratin fibers and novel n-heteroarylmethyl-m-phenylenediamine derivatives |
| 09/19/2002 | WO2002072558A1 Anti-thrombotic carboxylic acid amides, the production thereof and use of the same as medicaments |
| 09/19/2002 | WO2002072557A1 Bis(trifluoromethyl)hydantoins as intermediates for pharmaceutically active ingredients |
| 09/19/2002 | WO2002072068A2 Lipids, lipid compositions, liposomes, and lipoplexes |
| 09/19/2002 | WO2001072702A3 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/19/2002 | WO2001007020A3 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof |
| 09/19/2002 | US20020133023 Antitumor agents, osteoporosis |
| 09/19/2002 | US20020133012 Therapy for neurokinin sensitive disease |
| 09/19/2002 | US20020133006 Nucleophilic replacement |
| 09/19/2002 | US20020132841 Along with another fungicide, such as propamocarb, a benzothiadiazole, cyprodinil, a salicylate, spiroxamine, and a sulfamoylimidazole |
| 09/19/2002 | US20020132810 Novel heterocyclic amide derivatives |
| 09/19/2002 | US20020132797 DNA-cleaving antitumor agents |
| 09/19/2002 | US20020132796 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid. |
| 09/19/2002 | US20020132223 Methods for modulating activity of the FXR nuclear receptor |
| 09/19/2002 | US20020131951 Biodegradable poly(beta-amino esters) and uses thereof |
| 09/19/2002 | DE10113027A1 3-Diaminophenyl-acrylamide derivatives or their physiologically acceptable, water-soluble salts, used as developers in combination with couplers in oxidative dye formulations, especially for dyeing hair are new |
| 09/19/2002 | DE10111876A1 Bis(trifluormethyl)hydantoine als Zwischenprodukte für pharmazeutische Wirkstoffe Bis (trifluoromethyl) hydantoins as intermediates for pharmaceutical active substances |
| 09/19/2002 | DE10111842A1 Antithrombotische Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel Antithrombotic carboxamides, their preparation and their use as medicaments |
| 09/19/2002 | DE10109204A1 Use of new and known diphenylurea compounds for the preparation of a medicament for the inhibition of intracellular protein-degradation pathway |
| 09/19/2002 | CA2439231A1 Antithrombotic carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions |
| 09/18/2002 | EP1241163A1 Transesterification process |
| 09/18/2002 | EP1240154A1 Serine protease inhibitors |
| 09/18/2002 | EP1240147A1 Potassium channel inhibitors |
| 09/18/2002 | EP1240132A1 Adamantane derivatives |
| 09/18/2002 | EP1036059B1 Adamantane derivatives |
| 09/18/2002 | EP0917528B1 New amidino derivatives and their use as thrombin inhibitors |
| 09/18/2002 | EP0841923B1 1h-4(5)-substituted imidazole derivatives |
| 09/18/2002 | EP0823889B1 1,3-propane diol derivatives as bioactive compounds |
| 09/18/2002 | EP0772601B1 4,5-substituted imidazolyl compounds for the treatment of inflammation |
| 09/18/2002 | EP0772600B1 1,2-substituted imidazolyl compounds for the treatment of inflammation |
| 09/18/2002 | CN1370147A Novel integrin alpha V\ beta3 inhibitors |
| 09/18/2002 | CN1370146A Alpha/Beta integrin inhibitors |
| 09/17/2002 | US6452010 Process for the preparation of hydroxamic acid derivatives |
| 09/17/2002 | US6451839 Indole sPLA2 inhibitors |
| 09/17/2002 | US6451831 Treatment with hydantoin derivative |
| 09/17/2002 | US6451827 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 09/17/2002 | US6451824 Sulfonylaminocarboxylic acids |
| 09/17/2002 | US6451792 Matrix metalloprotease inhibitors |
| 09/17/2002 | US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/17/2002 | US6451736 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 09/17/2002 | US6451068 Oxidative color dyes for hair |
| 09/17/2002 | CA2057338C Diarylfluoromethane compounds |
| 09/16/2002 | CA2374885A1 Transesterification process |
| 09/12/2002 | WO2002070541A2 Peptide deformylase inhibitors |